Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) has received an average recommendation of “Strong Buy” from the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a buy rating and five have assigned a strong buy rating to the company. The average 12 month […]

View Entire Post